- Other Title
Search this article
The core technology of advanced medicines provided us opportunities of gene therapy for cancer patients and there are a rapidly growing number of cancer gene therapies worldwide. For malignant brain tumors, a suicide gene therapy using herpes simplex virus thymidine kinase gene and ganciclovir was opened in USA in 1992. Recently, we made a gene therapy protocol of our own, which used cationic multilamellar liposomes entrapped with inter-feron-β(IFN-β)gene as a vector. In April 2000, we started clinical trial of IFN-βgene therapy for the patients with malignant glioma. Until now, 5 patients received the treatment and then they are under evaluation on safety and usefulness. Here we introduce history, present, and prospect of gene therapy for malignant brain tumors.
- Japanese Journal of Neurosurgery
Japanese Journal of Neurosurgery 12 (5), 350-354, 2003
The Japanese Congress of Neurological Surgeons